India Diabetic Retinopathy Market Size & Outlook, 2025-2033
India Diabetic Retinopathy Market Insights
- Reed Intelligence analysis indicates that the India Diabetic Retinopathy Market size, valued at USD 460.48 Million in 2024, is expected to expand to USD 819.55 Million by 2033.
- The India market is forecasted to expand at a CAGR of 6.62% spanning 2026–2033.
- Proliferative Diabetic Retinopathy held the leading position among By Type segments in 2024, based on market size.
- Non-proliferative Diabetic Retinopathy is projected to post the fastest growth rate, sustaining its position as the most attractive By Type segment during the forecast horizon.
![India Diabetic Retinopathy Market Size, Share & Growth Report By [2033]](https://reedintelligence.com/uploads/charts/india-diabetic-retinopathy-market-india-by-type-35545.png)
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- In 2024, India accounted for 5.04% of the global Diabetic Retinopathy Market size.
- By 2033, United States is expected to lead the global Diabetic Retinopathy Market in terms of market size.
- Within Asia Pacific, China is projected to dominate the regional Diabetic Retinopathy Market size by 2033.
- Singapore is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 94.06 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 460.48 Million |
| Market Size In 2033 | USD 819.55 Million |
| Largest segment | Proliferative Diabetic Retinopathy |
| Units | Revenue in USD Million |
| CAGR | 6.62% (2025-2033) |
| Segmnetation Covered | |
| By Type |
|
| By Treatment Type |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
India Diabetic Retinopathy Market By Type 2025-2033 (USD Million)
| By Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proliferative Diabetic Retinopathy | XX.x | XX.x | XX.x | 268.37 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Non-proliferative Diabetic Retinopathy | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
India Diabetic Retinopathy Market By Treatment Type 2025-2033 (USD Million)
| By Treatment Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-VEGF Drug | XX.x | XX.x | XX.x | 206.02 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Steroid Implants | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Laser Surgeries | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Vitrectomy | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
